These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19598219)

  • 1. Successful treatment with daclizumab of refractory anaplastic lymphoma.
    Costa V; Oliva T; Norton L
    Pediatr Blood Cancer; 2009 Dec; 53(6):1130-1. PubMed ID: 19598219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term remission of children with relapsed and secondary anaplastic large cell non-Hodgkin lymphoma (ALCL) following treatment with pulsed dexamethasone and low dose etoposide.
    Stockklausner C; Behnisch W; Mechtersheimer G; Möller P; Kulozik AE
    Pediatr Blood Cancer; 2008 Jan; 50(1):126-9. PubMed ID: 16609950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission of a refractory, anaplastic large-cell lymphoma after treatment with daclizumab.
    Lindén O
    N Engl J Med; 2004 Sep; 351(14):1466-7. PubMed ID: 15459315
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term disease control of refractory anaplastic large cell lymphoma with vinblastine.
    Garner R; Li Y; Gray B; Zori R; Braylan R; Wall J; Hunger SP
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):145-7. PubMed ID: 19194204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
    Vinogradova IuE; Lutsenko IN; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Gorgidze LA; Ryzhikova NA; Valiev TT; Giliazitdinova EA; Dzhulakian UL; Egorova EK; Zvonkov EE; Krasil'nikova BB; Magomedova AU; Margolin OV; Mar'in DS; Kremenetskaia AM; Kravchenko SK; Vorob'ev AI
    Ter Arkh; 2008; 80(7):33-7. PubMed ID: 18763592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous anaplastic large cell lymphoma.
    Daar G; Küpeli S; Yalçin B; Kesik V; Orhan D; Büyükpamukçu M
    Pediatr Hematol Oncol; 2010 Oct; 27(7):558-63. PubMed ID: 20624005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
    Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
    J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study.
    Woessmann W; Zimmermann M; Lenhard M; Burkhardt B; Rossig C; Kremens B; Lang P; Attarbaschi A; Mann G; Oschlies I; Klapper W; Reiter A
    J Clin Oncol; 2011 Aug; 29(22):3065-71. PubMed ID: 21709186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology.
    Brugières L; Pacquement H; Le Deley MC; Leverger G; Lutz P; Paillard C; Baruchel A; Frappaz D; Nelken B; Lamant L; Patte C
    J Clin Oncol; 2009 Oct; 27(30):5056-61. PubMed ID: 19738127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary CD30/ALK-1 positive anaplastic large cell lymphoma of the skeletal muscle in a child.
    Driss M; Abbes I; Mrad K; Sassi S; Oubich F; Barsaoui S; Romdhane KB
    Pathologica; 2009 Apr; 101(2):97-100. PubMed ID: 19886557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody).
    Osborne GE; Pagliuca A; Ho A; du Vivier AW
    Br J Dermatol; 2006 Sep; 155(3):617-20. PubMed ID: 16911291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.
    Le Deley MC; Rosolen A; Williams DM; Horibe K; Wrobel G; Attarbaschi A; Zsiros J; Uyttebroeck A; Marky IM; Lamant L; Woessmann W; Pillon M; Hobson R; Mauguen A; Reiter A; Brugières L
    J Clin Oncol; 2010 Sep; 28(25):3987-93. PubMed ID: 20679620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.
    Olin RL; Nichols KE; Naghashpour M; Wasik M; Shelly B; Stadtmauer EA; Vogl DT
    Am J Hematol; 2008 Sep; 83(9):747-9. PubMed ID: 18615554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV-related multiple non-Hodgkin lymphomas].
    Gotoh M; Kitahara T; Iguchi T; Izumi M; Mukai K; Ohyashiki K
    Rinsho Ketsueki; 2008 Nov; 49(11):1552-5. PubMed ID: 19047787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daclizumab in anaplastic large cell lymphoma.
    Grigg A
    Leuk Lymphoma; 2006 Jan; 47(1):175. PubMed ID: 16321847
    [No Abstract]   [Full Text] [Related]  

  • 16. Daclizumab therapy for children with corticosteroid-resistant acute graft-vs.-host disease.
    Schechter T; Afzal S; Finkelstein Y; Koren G; Doyle J; Dupuis LL
    Pediatr Transplant; 2009 May; 13(3):332-7. PubMed ID: 18482218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.
    Zhang M; Yao Z; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Janik J; Brechbiel MW; Waldmann TA
    Blood; 2006 Jul; 108(2):705-10. PubMed ID: 16551968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial.
    Wrobel G; Mauguen A; Rosolen A; Reiter A; Williams D; Horibe K; Brugières L; Le Deley MC;
    Pediatr Blood Cancer; 2011 Jul; 56(7):1071-7. PubMed ID: 21280197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic monoclonal antibody therapy (daclizumab) in the treatment of cicatrizing conjunctivitis in stevens-johnson syndrome, refractory to conventional therapy.
    Fiorelli VM; Dantas PE; Jackson AT; Nishiwaki-Dantas MC
    Curr Eye Res; 2010 Dec; 35(12):1057-62. PubMed ID: 20929291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience.
    Miano M; Cuzzubbo D; Terranova P; Giardino S; Lanino E; Morreale G; Castagnola E; Dini G; Faraci M
    Bone Marrow Transplant; 2009 Mar; 43(5):423-7. PubMed ID: 18850021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.